Skip to main content
SpringerLink
Log in

Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Badros A, Singh Z, Dhakal B, Kwok Y, MacLaren A, Richardson P, Trikha M, Hari P (2017) Marizomib for central nervous system-multiple myeloma. Br J Haematol 177(2):221–225

    Article  PubMed  Google Scholar 

  2. Luetkens T, Yousef S, Radhakrishnan SV, Atanackovic D (2017) Current strategies for the immunotherapy of multiple myeloma. Oncology (Williston Park) 31(1):55–63

    Google Scholar 

  3. Singh N (2016) Recent advances in engineered T cell therapies targeting B cell malignancies. Discov Med 22(121):215–220

    PubMed  Google Scholar 

  4. Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN (2016) T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions ofmultiple myeloma. Blood 128(13):1688–1700

    Article  CAS  PubMed  Google Scholar 

  5. Atanackovic D, Radhakrishnan SV, Bhardwaj N, Luetkens T (2016) Chimeric antigen receptor (CAR) therapy for multiple myeloma. Br J Haematol 172(5):685–698

    Article  PubMed  Google Scholar 

  6. Geyer MB, Brentjens RJ (2016) Review: current clinical applications of chimeric antigen receptor (CAR) modified T cells. Cytotherapy 18(11):1393–1409

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants 81670104 and 81570201 from the National Natural Science Foundation of China (NSFC).

Author information

Authors and Affiliations

  1. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

    Chen Tian, Hongliang Yang, Lei Zhu, Qing Zhang, Zeng Cao & Yizhuo Zhang

Authors
  1. Chen Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongliang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zeng Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yizhuo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

C.T. drafted the paper. H.Y. cared for the patient. L.Z. collected the data. Q.Z. and Z.C. contributed to the writing of the report. Y.Z. critically revised the paper. All authors approved all versions including the final version and are responsible for the accuracy and integrity of all aspects of the manuscript.

Corresponding authors

Correspondence to Chen Tian or Yizhuo Zhang.

Ethics declarations

Written consent to publish was obtained. The study design was approved by the ethics review board of the Tianjin Medical University.

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, C., Yang, H., Zhu, L. et al. Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement. Ann Hematol 96, 1407–1410 (2017). https://doi.org/10.1007/s00277-017-3029-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-3029-3

Search

Navigation